Table 4.
The role of kinases in the axonal response to NGF-coated beads
| Treatment | Protocol | % Filopodial responses (n) |
|---|---|---|
| 100 nm k252a | 1 | 19 (127)* |
| 100 nm KT5926 | 1 | 43 (126)* |
| 500 nm KT5926 | 1 | 30 (178)* |
| 100 nmk252a | 2 | 30 (168)**, *** |
| 100 nmKT5926 | 2 | 59 (181)**, **** |
| 1:500 DMSO | 2 | 52 (107) |
| 50 nm wortmannin | 1 | 51 (147)* |
| 100 nm wortmannin | 1 | 26 (133)* |
| 10 μm LY294002 | 1 | 47 (217)* |
| 50 μmLY294002 | 1 | 43 (152)* |
| 100 μmLY294002 | 1 | 34 (188)* |
Protocol 1: Drug was added to the culture 1 hr before the introduction of beads, and cells were fixed 3 hr later. Protocol 2: Drug and beads were coadministered, and cells were fixed 30 min later. Data on DMSO controls (3 hr) are presented in Table 1. Fischer’s exact test (one-tailed) was used to compare results obtained using protocol 1 with DMSO controls, and results obtained using protocol 2 were compared with each other and with the 30 min DMSO control. n refers to the number of bead–axon interactions scored.
*p < 0.0001; **p < 0.0001; ***p < 0.0002; ****p > 0.15.